FDA less trusted than pharma, says poll

Share this article:
A poll suggests that, amid drug safety worries, the FDA is less trusted than the drug industry.
A recent Wall Street Journal Online/Harris Interactive Health Care Poll found that six in 10 adults gave the agency a negative rating on the function they rated its most important: ensuring the safety and efficacy of prescription drugs.

Eighty percent of respondents said they were very or somewhat concerned about the agency's ability to “make independent decisions that will ensure that patients have access to safe and effective medicines.” Asked how good a job the FDA is doing on that front, 58% said “fair” or “poor,” while just 36% said “good” or “excellent,” a reversal from ratings two years ago.

By comparison, only 36% of those surveyed in a recent Harris Interactive industry reputation poll said pharmaceutical firms were doing a bad job of serving consumers, with 61% saying they were doing a good job.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.